Xiaoling Ma

5.3k total citations · 1 hit paper
116 papers, 3.3k citations indexed

About

Xiaoling Ma is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaoling Ma has authored 116 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 22 papers in Immunology and 20 papers in Cancer Research. Recurrent topics in Xiaoling Ma's work include Epigenetics and DNA Methylation (14 papers), Reproductive Biology and Fertility (13 papers) and Reproductive System and Pregnancy (12 papers). Xiaoling Ma is often cited by papers focused on Epigenetics and DNA Methylation (14 papers), Reproductive Biology and Fertility (13 papers) and Reproductive System and Pregnancy (12 papers). Xiaoling Ma collaborates with scholars based in China, United States and Hong Kong. Xiaoling Ma's co-authors include Xiaoxi Sun, Liangfei Xu, Weihong Zeng, Wenjiao Chang, Tengchuan Jin, Huan Ma, Hongliang He, Dan Zhao, Yuanyuan Dai and Yicong Wan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Xiaoling Ma

113 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae

2017 462 citations Xiaoling Ma et al. profile →

Peers

Countries citing papers authored by Xiaoling Ma

Since Specialization

Citations

This map shows the geographic impact of Xiaoling Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Ma more than expected).

Fields of papers citing papers by Xiaoling Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Ma. The network helps show where Xiaoling Ma may publish in the future.

Co-authorship network of co-authors of Xiaoling Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Ma. A scholar is included among the top collaborators of Xiaoling Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Ma. Xiaoling Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolomic and transcriptomic profiling of HNSCC identifies AMIGO2 as a therapeutic target modulating tumor microenvironment 2025 ·npj Precision Oncology ·Gan Liu, Xinfeng Yao, Yuchen Hou, Wentao Deng, Liyu Zhang, (unknown), Panpan Huang, Wenjiao Chang, Haiyan Huang, Lan Shi, Qianqian Zhou, Yanqing Wang, Jia Chen, Wenchao Gu, Xiaoling Ma, Yu Zhou, Honghong Liu, Shanshan Zhang, Zongcheng Yang	0
2	Furazolidone reduces the pathogenesis of Trueperella pyogenes and Pseudomonas aeruginosa co-infection in a mouse model 2024 ·Heliyon ·Nan Yang, (unknown), (unknown), Yi Wu, (unknown), (unknown), Xiaoling Ma, Xikun Zhou, Xiuyue Zhang, Kelei Zhao, Lianming Du, Ting Huang	2
3	LINC01012 upregulation promotes cervical cancer proliferation and migration via downregulation of CDKN2D 2023 ·Oncology Letters ·Keyi Zhang, Xiao Ni, Xiaoling Ma, Rui Sun, Jiangnan Qiu, (unknown)	5
4	The glucagon-like peptide-1 (GLP-1) analog exenatide ameliorates intrauterine adhesions in mice 2021 ·Peptides ·Xiaoling Ma, Yuan Ding, (unknown), Yixiang Wang, (unknown), (unknown), (unknown), (unknown), Yigan Zhang, Junqiang Niu, (unknown), (unknown), (unknown)	16
5	Lymphocyte–monocyte–neutrophil index: a predictor of severity of coronavirus disease 2019 patients produced by sparse principal component analysis 2021 ·Virology Journal ·Yingjie Qi, (unknown), Huiming Li, (unknown), Shuqin Zhang, Xiaoling Ma	5
6	Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis 2020 ·Bioscience Reports ·Xiaoling Ma, Jinhui Liu, Hui Wang, Yi Jiang, Yicong Wan, Yankai Xia, Wenjun Cheng	18
7	Serum IgA, IgM, and IgG responses in COVID-19 2020 ·Cellular and Molecular Immunology ·Huan Ma, Weihong Zeng, Hongliang He, Dan Zhao, (unknown), Peigen Zhou, Linzhao Cheng, Yajuan Li, Xiaoling Ma, Tengchuan Jin	303
8	A microRNA–Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer 2020 ·DNA and Cell Biology ·Jinhui Liu, Jing Yang, Feng Gao, Siyue Li, Sipei Nie, Huangyang Meng, Rui Sun, Yicong Wan, Yi Jiang, Xiaoling Ma, Wenjun Cheng	11
9	LukS‐PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor 2019 ·Cancer Medicine ·Peng Zhang, (unknown), (unknown), (unknown), Changcheng Zhao, Wenjiao Chang, Xiaoling Ma	13
10	LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis 2019 ·Radiology and Oncology ·Wei Wang, Liang Ge, Xiaojuan Xu, Ting Yang, Yue Yuan, Xiaoling Ma, (unknown)	57
11	Effects of PRDM14 Silencing on Parthenogenetically Activated Porcine Embryos 2018 ·Cellular Reprogramming ·(unknown), Yutian Wang, Jian Zhang, Sheng Zhang, Xiaoling Ma, Xinglan An, (unknown), Xueming Zhang, Ziyi Li, Bo Tang	1
12	EIF5A1 promotes trophoblast migration and invasion via ARAF-mediated activation of the integrin/ERK signaling pathway 2018 ·Cell Death and Disease ·Jing Zhang, (unknown), Fu‐Ju Tian, Weihong Zeng, Xiaorui Liu, Xiaoling Ma, Xiao Li, Qin Shi, Cuifang Fan, Yi Lin	36
13	MiR-628-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at FGFR2 2017 ·Biochemical and Biophysical Research Communications ·Ming Li, (unknown), Xiaoling Ma, Xiaolong Lin, Yanan You, Yiying Li, Tong Chen, Hua Jiang	35
14	Is LukS-PV a novel experimental therapy for leukemia? 2016 ·Gene ·(unknown), Xiaoling Ma, Fang Deng	4
15	Functional analysis of bovine Nramp1 and production of transgenic cloned embryosin vitro 2013 ·Zygote ·Xiang Cheng, (unknown), Yajun Liu, Jie Deng, Xiaoling Ma, Huayan Wang	3
16	Characterization of the proximal region of the goat NANOG promoter that is used for monitoring cell reprogramming and early embryo development 2013 ·The Veterinary Journal ·Yanjie Guo, Lei Lei, Xiaoling Ma, Huayan Wang	4
17	Pluripotent Male Germline Stem Cells from Goat Fetal Testis and Their Survival in Mouse Testis 2011 ·Cellular Reprogramming ·Jinlian Hua, Haijing Zhu, Shaohui Pan, Chao Liu, Junwei Sun, Xiaoling Ma, Wuzi Dong, Weishuai Liu, Wei Li	36
18	Application of a nano-antimicrobial film to prevent ventilator-associated pneumonia: A pilot study 2011 ·AFRICAN JOURNAL OF BIOTECHNOLOGY ·(unknown), Xiaoling Ma, (unknown), Jun Cao, Wings T.Y. Loo, Liang Hao, Mary Cheung, Louis W.C. Chow, LJ Jin	7
19	A Study on ALA/AASL Standard for Initial Preparation of School Librarians(2010) 2011 ·Xiandai jiaoyu jishu ·Xiaoling Ma	2
20	In vitro culture of fibroblast-like cells from postmortem skin of Katahdin sheep stored at 4°C for different time intervals 2011 ·In Vitro Cellular & Developmental Biology - Animal ·Mahipal Singh, Xiaoling Ma, (unknown), Govind Kannan	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact